Yervoy (ipilimumab) - BMS
Treatment Strategies for Advanced Cutaneous Squamous Cell Carcinoma Following Anti-PD-1 Immunotherapy Failure: A Systematic Review of the Literature and Ongoing Trials. (PubMed, Cancers (Basel)) - Sep 27, 2026 - " However, current evidence is insufficient to establish superiority over alternative treatments. Other treatment strategies, such as ipilimumab, oncolytic virotherapy and chemo-immunotherapy, show clinical promise warranting further investigation." 
Journal • Review • Non-melanoma Skin Cancer • Oncology • Squamous Cell Carcinoma • Squamous Cell Skin Cancer
http://www.ncbi.nlm.nih.gov/pubmed/42795027
 
Anirban Mandal; Christopher Jones; Embiye Adala; Hamish Thomson; Joseph J Sacco
 
Sep 27, 2026
 
Prev Next